FLASH (FLICE-associated huge protein or CASP8AP2) is a large multifunctional protein that is involved in many cellular processes associated with cell death and survival. It has been reported to promote apoptosis, but we show here that depletion of FLASH in HT1080 cells by siRNA interference can also accelerate the process. As shown previously, depletion of FLASH halts growth by down-regulating histone biosynthesis and arrests the cell cycle in S-phase. FLASH knockdown followed by stimulating the cells with Fas ligand or anti-Fas antibodies was found to be associated with a more rapid cleavage of PARP, accelerated activation of caspase-8 and the executioner caspase-3 and rapid progression to cellular disintegration. As is the case for most anti-apoptotic proteins, FLASH was degraded soon after the onset of apoptosis. Depletion of FLASH also resulted in the reduced intracellular levels of the anti-apoptotic proteins, MCL-1 and the short isoform of cFLIP. FLASH knockdown in HT1080 mutant cells defective in p53 did not significantly accelerate Fas mediated apoptosis indicating that the effect was dependent on functional p53. Collectively, these results suggest that under some circumstances, FLASH suppresses apoptosis.
Introduction
FLASH (CASP8AP2) is a large multifunctional protein that has been implicated in many different cellular processes including apoptosis, histone mRNA processing, S-hase progression, NFkappa B activation and the regulation of transcription. In 1999, Imai et al. [1] discovered a 220 kDa protein, which they designated FLICE associated huge protein or FLASH, since it associates with caspase-8 and promotes Fas induced apoptosis. There are two major apoptotic pathways. The binding of ligands to the FAS receptor, a member of the TNF family of plasma membrane receptors, triggers the assembly of the death inducing signaling complex (DISC) (Figure 1 ). Imai et al. [1] showed that in 293 T cells, FLASH associates with the adaptor protein, FADD, recruiting caspase-8 to the activated DISC. Oligomerization of FLASH results in the proteolytic cleavage and activation of caspase-8. Caspase-8 in turn activates other caspases including the executioner protease, caspase-3.
In the intrinsic or mitochondrial apoptotic pathway several intra-and extracellular apoptotic signals induce the release of proteins from the mitochondria including cytochrome c (Figure 1 ). Cytochrome c associates with the apoptotic protease activating factor 1 (APAF-1) to form the apoptosome. The recruitment of pro-caspase-9 molecules to the apoptosome promotes its proteolytic activation which leads to the activation of the downstream executioner, caspase-3. The mitochondrial apoptotic pathway also serves to amplify the apoptotic response triggered by the activation of the Fas receptor [2] .
The response to stimulation of the Fas receptor differs according to cell type [3] . Type I cells such as SKW6. 4 and H9 cells quickly assemble large amounts of DISC upon binding of the Fas ligand with the rapid activation of caspase 8 and caspase 3. Very little DISC is formed upon stimulation of Type II cells such as CEM and Jurkat cells. However, sufficient caspase-8 is activated to cleave the cytoplasmic protein, Bid. Truncated Bid, tBid, relocalizes to the mitochondria where it binds to Bak/Bax which together with Bad promote the formation of mitochondrial pores and the release of cytochrome C. The loss of the mitochondrial membrane potential occurs prior to the activation of caspase-3 and caspase-8. Thus, the mitochondrial pathway is indispensible for type II cells to undergo apoptosis.
FLASH was originally thought [1] to be exclusively a cytoplasmic protein but more recent studies showed that it is primarily nuclear and that it is localized within a variety of discrete nuclear bodies. FLASH was identified [4] as an indispensible component of Cajal bodies, small nuclear organelles involved in numerous cell functions. RNA interference showed that depletion of FLASH resulted in disruption of Cajal body structure and relocation of its components. In other studies, FLASH was found [5, 6] to be primarily localized in promyelocytic leukemia nuclear bodies which are involved in apoptosis, the regulation of senescence and tumor suppression. FLASH associates with Sp100 [5, 7] , an essential PML component. Although PMLs are distinct nuclear bodies, they are often found in association with Cajal bodies and other nuclear organelles. Immunofluorescence microscopy [8] showed that FLASH was 100% coincident with NPAT, the nuclear protein localized near histone locus bodies [9] on chromosome 6 and 12. HLBs are often associated with but are not identical to the coilin containing Cajal bodies, although the two organelles co-localize during the S phase of the cell cycle. These authors [8, 10] did not find FLASH in other nuclear bodies such as nuclear speckles or PML bodies.
In 2007, Milovic-Holm et al. [7] made the intriguing observation that activation of the Fas receptor triggers the translocation of FLASH from the PML nuclear bodies to the cytoplasm, where it associates with caspase-8 at the mitochondrial surface, thereby activating the mitochondrial apoptotic pathway. Leptomycin B, an inhibitor of Crm1-dependent nuclear export, blocked egress of FLASH from the nucleus and prevented mitochondrial damage. Caspase-8 was nevertheless still activated, albeit to a lesser extent, presumably at the DISC assembly. FLASH depletion by siRNA interference followed by induction of the Fas receptor with anti-Fas antibodies for 7 hours resulted in a 57% decrease in apoptosis. A recent study [11] may provide insight into the translocation mechanism. FLASH was shown to form a complex with Ro52, an E3 ubiquitin ligase that moves along cytoplasmic microtubular networks. Simultaneous overexpression of Ro52 and FLASH induces the relocation of another apoptotic protein, DAXX, from the nucleus to the cytoplasm.
Barcaroli et al. [8, 10] discovered that depletion of FLASH by RNA interference abolished histone biosynthesis and induced cell cycle arrest in S phase. It was subsequently shown [12] that FLASH is necessary for proper processing of the 39-end of the histone pre-mRNA. FLASH also plays a significant role in the transcriptional regulation of histone genes. The FLASH binding partner, NPAT (p220), is an activator of histone gene transcription [9, 13] under the control of cyclin E/Cdk2 kinase. Moreover, CHIP assays demonstrated that FLASH interacts with histone gene promoter sequences [8] . The interaction of FLASH with the arsenite resistance protein, Ars2, a protein involved in the formation of microRNA, was shown [14] to be indispensible for cell cycle progression. Similar results [15] were observed during embryogenesis where FLASH cooperates with the transcription factor p73 to regulate histone gene transcription and cell cycle progression. These authors also found that FLASH knockout is lethal in embryonic mice.
FLASH is also a co-activator of c-Myb, a transcription factor normally associated with growth and survival. Both proteins colocalize at active transcription loci [16, 17] . The enhancement of transcriptional activity by FLASH is comparable with that obtained with the c-Myb co-activator, P300. The E3 SUMOprotein ligase, PIAS1, was also found to interact with FLASH and enhance its transcriptional activity and the expression of genes under control of c-Myb [17] . In some instances, FLASH was found to repress transcription. It binds to and inhibits the activity of the p160 nuclear receptor coactivator (GRIP 1) thus suppressing the expression of the glucocorticoid receptor [18] in human colon carcinoma cells. In contrast, it enhances transactivation of both the glucocorticoid and mineralocorticoid receptors in mouse hippocampal cells but had only a small repressive effect in neuroblastoma cells [19] . FLASH also modulates the activity of the transcription factor NF-kappa B via a TRAF-2 dependent pathway [20, 21] Depletion of FLASH by RNA interference abolishes the activation of NF-kappa B, while overexpression of FLASH activates its activity in a dose dependent manner.
Thus, FLASH is involved in several pathways related to cell death, growth and survival. Those studies [1, 7] that specifically examined its role in cell death, suggest that it promotes apoptosis. We report here that under certain circumstances, it can also effectively suppress apoptosis.
Materials and Methods

Antibodies and Reagents
Antibodies used for this study were rabbit anti-FLASH (Bethyl Laboratories, Montgomery, TX), mouse anti-caspase-8 (9746), rabbit anti-caspase-3 (9662), rabbit anti-cleaved caspase-3 (9664), rabbit anti-poly (ADP-ribose) polymerase, PARP (9542), rabbit anti-cleaved PARP (5625), rabbit anti-MCL-1 (5453) (Cell Signaling, Beverly, MA); mouse monoclonal b-tubulin (sc-5274), mouse monoclonal anti-p53 (sc-126), rabbit anti-FLASH M300 (sc-9088), mouse anti-NPAT (sc-136007) and mouse anti-PML (sc-966), mouse anti-FLIPS/L (sc-5276), rabbit anti-IKKa (sc7607) (Santa Cruz Biotechnology, Santa Cruz, CA); rabbit anti-histone H3 (21137) (Signalway Antibody, Pearland, TX), rabbit anti-HDAC1(10197-1-AP), rabbit anti-coilin (10967-1-AP) and rabbit anti-p21(10240-1-AP) (Proteintech Group, Inc). A panel of caspase inhibitors (FMKSP01) and recombinant human Fas Ligand/ Figure 1 . The role of FLASH in the apoptotic pathways. In the extrinsic pathway, the Fas ligand (FasL) binds to the Fas receptor and triggers the assembly of the DISC complex. FLASH binds pro-caspase 8 and translocates to the DISC complex where it associates with FADD. Active caspase-8 is formed at the DISC by proteolytic cleavage. The active caspase then cleaves and activates the executioner protease, caspase-3. c-FLIP short is also part of the DISC and inhibits the activation of caspase-8. Caspase-3 is also activated in the intrinsic or mitochondrial pathway triggered by a variety of apoptotic signals that culminate in the formation of pores that allow the release of cytochrome c. Cytochrome c associates with Apaf-1 forming the apoptosome which recruits and activates pro-caspase 9, which in turn activates pro-caspase 3. The translocation of FLASH from the nucleus to the mitochondria is thought to be one of the signals that initiate the mitochondrial apoptotic pathway. The extrinsic and intrinsic pathways are linked by Bid, a cytoplasmic proapoptotic protein that is cleaved by caspase-8 generated at the DISC complex. Once cleaved, the truncated Bid (tBid) migrates to the mitochondria where it interacts with Bax and Bad, proteins that promote mitochondrial permeability and cyctochrome c release. FLASH also binds to the histone gene locus where it participates in processing the histone mRNA that is necessary for Sphase progression. FLASH is also a coactivator of c-Myb which controls the expression of several proteins that play a role in proliferation, including the anti-apoptotic protein, BCL-2. P53 down regulates the expression of BCL-2 and another pro-apoptotic protein, MCL-1. doi:10.1371/journal.pone.0032971.g001 TNF9SF (126-FL-010) were purchased from R&D (Minneapolis, MN). MG132, cycloheximide (CHX), actinomycin D were from Sigma and adriamycin was from Santa Cruz. Staurosporine (STS) was from Invitrogen (Carlsbad, CA).
Cell Culture and Induction of Apoptosis
HT1080 cells (wild type p53) and HT1080-6TG (mutant p53) (a gift of Dr Eric J Stanbridge, Department of Microbiology and Molecular Genetics, University of California, Irvine, CA) and HeLa cells (ATCC) were cultured in DMEM containing 10% fetal bovine serum, 100 units/ml penicillin, 100 mg/ml streptomycin, in 5% CO 2 at 37uC. The MCF10A cell line, obtained from Drs. Santner and Pauley (Karmanos Cancer Institute, Wayne State University, Detroit, MI), was cultured according to the original publications [22, 23] . For the induction of apoptosis, the cells were incubated with 100 ng/ml of the recombinant Fas ligand (R&D, Minneapolis, MN) or 1 mg/ml of the agonist mouse monoclonal anti-human CD95 (Fas) antibody (Invitrogen, AHS9552) for the indicated periods of time in 5% CO 2 at 37uC. Alternatively, apoptosis was induced by incubating the cells with 1 mM staurosporine. The progression through apoptosis was monitored by measuring the activation of the caspases and the cleavage of PARP. The distribution of cells in different phases of the cell cycle was measured using a Becton-Dickinson FACScan cytofluorometer at the Wayne State University, Karmanos Cancer Institute, Flow Cytometry Facility.
SiRNA Interference
HT1080 cells were grown in 6 well plates to 20-30% confluence. Cells were transfected with siRNA directed against the FLASH mRNA and, as a negative control, with a scrambled siRNA, using RNAi Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA), according to the manufacturer's protocol. The oligonucleotides used for these studies were purchased from Invitrogen (Carlsbad, CA). 1) FLASH Stealth RNAi TM siRNA HSS115171: GAAACA-GAAUGAACCAAAGACUGAU; 2) FLASH Stealth RNAi TM siRNA HSS115172: GAAAGCUGAGAGUGGUCCAAAUGAA; 3) FLASH Stealth RNAi TM siRNA HSS115173: CCUGUG-GUAAUGGAUGUAUUACAAA. To assess the extent to which the expression of FLASH was suppressed, cell extracts were isolated at various times following transfection and the cell lysate was analyzed by Western blotting. Equivalent amounts of total protein were analyzed as determined by the Lowry method using bovine serum albumin (BSA) as a standard. Immunoblotting of b-tubulin or b-actin was used to verify that equal amounts of total protein had been loaded on the gel. The same procedure was used to suppress p53 expression using a commercial siRNA of proprietary sequence (Santa Cruz, sc-29435) and siRNA against coilin was purchased from Invitrogen (HSS112012).
Western blot Analysis
Total cell extracts were prepared in a lysis buffer containing 20 mM Tris-HCl, pH 7.5, 137 mM NaCl, 1% Triton X-100, 10% glycerol, 0.2 mM PMSF supplemented with a 16 cocktail of phosphatase and protease inhibitors (Sigma). Protein samples were heated at 95uC for 10 min and separated by SDS-PAGE using 4-12% gradient gel and transferred onto a nitrocellulose membrane. Western blots were developed using the Western Lighting Plus-ECL reagent (NEL104001EA, Perkin Elmer, Waltham, MA).
Cell Fractionation
Cytoplasmic and nuclear fractions were isolated using the Qproteome Nuclear Protein Kit (Qiagen) according to the manufacturer's protocol. The purity of the fractions was confirmed by Western Blotting using anti-PARP, anti-HDAC1 (nuclear markers) and anti-b-tubulin (cytoplasmic marker) antibodies.
Immunofluorescence microscopy
Cells grown on cover slips in 6-well plates were fixed with cold methanol at 220uC for 10 min and then blocked with 3% BSA in PBS for 1 h at room temperature. Cells were incubated with the primary antibody, rabbit anti-FLASH M-300, mouse anti-NPAT monoclonal antibody or mouse anti-PML monoclonal antibody, alone or in combination, overnight at 4uC. The cells were then incubated with chicken anti-rabbit IgG antibody conjugated with Alexa Fluor 594 (1:2,000) and a chicken anti-mouse IgG antibody conjugated with Alexa Fluor 488 (1:2,000) (Molecular Probes, Invitrogen, Carlsbad, CA) as secondary antibodies for 1 h at room temperature. After extensive washing with PBS, the cells were counterstained with Hoechst 33342, mounted and visualized using a Leica TCS SP5 Laser Scanning Confocal Microscope (Karmanos Cancer Institute Imaging and Cytometry Resources Core Facility). The images were analyzed using the Leica LAS AF Imaging software.
Results
Intracellular localization of FLASH
In agreement with previous studies [6, 7, 10] , cell fractionation showed that FLASH was localized exclusively in the nuclear extract (Nuc) in the absence of apoptotic signals (Figure 2A ). The purity of the cell fractions was assessed by Western blotting of the nuclear marker proteins, poly ADP-ribose polymerase (PARP), the nuclear protein ataxia-telangiectasia locus (NPAT) and histone deacetylase I (HDAC1) and the cytoplasmic marker b-tubulin. There was little or no cross contamination of nuclear and cytosolic fractions.
Within the nucleus, FLASH has variously been reported to be associated with Cajal bodies [4] , PML bodies (Promyelocytic leukemia nuclear bodies) [6, 7] and in histone gene clusters [8] . In HT1080 cells, immunofluorescence microscopy showed ( Figure 2B ) that FLASH was concentrated in a relatively small number of discrete foci within the nucleus. In agreement with the cell fractionation results, no FLASH could be detected in the cytoplasmic compartment. When the cells were co-stained with antibodies directed against PML, there was little colocalization of FLASH and PML. In contrast, staining the cells with antibodies directed against, NPAT, a major component of the histone cluster loci, there was 100% overlap. Each of the 2-4 NPAT histone gene loci also contained FLASH, although there were additional nonoverlapping FLASH foci present in other nuclear bodies.
Three oligonucleotides complementary to different regions of the FLASH mRNA were used to silence the expression of FLASH. All three reduced the intracellular concentration of FLASH by at least 90% as determined by Western blotting of whole cell extracts ( Figure 3A) . Cells subjected to RNA interference with each siRNA exhibited the same phenotype with no detectable off target effects. Immunofluorescence microscopy ( Figure 3B) showed that a comparable percentage of the cells lacked FLASH. In contrast, there was no effect on the number or distribution of nuclear PML bodies, as detected with anti-PML antibodies, when the expression of FLASH was suppressed.
FLASH is necessary for cell cycle progression in HT1080 cells
As reported previously [8] in other cell lines, depletion of FLASH also caused cell cycle arrest in S phase ( Figure 3C ) in HT1080 cells, presumably due to the reduction of histone gene expression. In cells transfected with the scrambled siRNA control for 72 hours, 69% were found in G0-G1 and 16% in S phase. In contrast, 10% are in G0-G1 phase and 60% of the cells are in S phase in cells transfected with FLASH siRNA. Thus, the cells can progress through the G1/S check point, but cannot exit S phase. Similarly, FLASH knockdown resulted in S-phase arrest in HeLa, MCF10A and MCF-7 cells (data not shown). Figure 4B) . Quantification of the bands on the gel ( Figure 4B ) indicated that after three hours, there was an approximately eleven fold increase in the activation of caspase 8 in cells depleted of FLASH. After six hours, there was still an approximately three fold higher caspase-8 activity when FLASH was knocked down. There appeared to be a slight depletion of coilin six hours post stimulation of the receptor when FLASH expression was suppressed, an observation that may suggest that a fraction of the FLASH may be associated with coilin containing Cajal bodies. The significantly more rapid degradation of the anti-apoptotic protein, poly ADP-ribose polymerase (PARP), a hallmark of the early stages of apoptosis, in cells lacking FLASH was a further indication that FLASH depleted cells are more sensitive to Fas mediated apoptosis ( Figure 4C ). Immunofluorescence micrographs of cells stained with antibodies directed against cleaved caspase-3 ( Figure 4D ) were taken 6 hours following stimulation of HT1080 cells with Fas antibodies. The micrographs showed that caspase-3 activation had progressed more rapidly in cells depleted of FLASH. After 16 hours, most of the cells lacking FLASH had either died or were in advanced stages of apoptosis ( Figure 4E ). Similar results were obtained for MCF-10A cells (data not shown).
Silencing FLASH gene expression accelerates the onset of apoptosis
RNA interference of FLASH expression did not induce apoptosis in HT1080 cells in the absence of apoptotic signals at all times tested up to 72 hours. However, apoptosis in the FLASH depleted cells proceeded much more rapidly when the Fas receptor was activated as compared to the cells transfected with control siRNA. A time course over six hours following stimulation of the Fas receptor (Figure 4A) clearly showed that both caspase 8 and the executioner caspase, caspase 3, are activated by proteolytic cleavage much more rapidly than the control cells. Similar results were obtained for caspase 8 when the receptor was activated by the recombinant human Fas ligand (
The Intracellular level of FLASH decreases during apoptosis
Anti-apoptotic proteins are usually rapidly degraded once apoptosis has been initiated. The stability of FLASH was monitored during apoptosis under conditions where proteasomal degradation was blocked. MG132 is a potent proteasome inhibitor and significantly augments the rate at which many cell types progress through apoptosis perhaps as a consequence of blocking the proteasomal degradation of pro-apoptotic proteins [24] . The accelerated cleavage of caspase-8 indicated that MG132 also promotes apoptosis of HT1080 cells ( Figure 5A ). Moreover, the intracellular level of P21, a protein which turns over very rapidly, significantly increased confirming that proteasomal degradation had been inhibited.
The intracellular level of FLASH, like the anti-apoptotic protein, PARP, rapidly decreased during apoptosis in cells stimulated by FasL and MG132 ( Figure 5B ). The extensive cleavage of pro-caspase-3 served as a marker of apoptosis. However, the degradation of FLASH was completely arrested by the potent caspases 3, 8 and 10 inhibitors (Figure 5B ), indicating that FLASH, like PARP, was degraded by caspases once apoptosis was underway. Similar results were obtained when apoptosis was initiated with staurosporine ( Figure 5C ). The time course following exposure to staurosporine showed that FLASH and PARP, as well as the Cajal body component, coilin, rapidly disappeared from the cell extract as apoptosis progressed. In this experiment, IKK and b-actin served as negative controls. FLASH was also degraded during apoptosis resulting from exposure to UV light ( Figure 5D ). DNA damage was confirmed by immunoblotting of phospho-p95/ NBS1, a protein that is part of a complex that is phosphorylated by ATM in response to DNA breaks [25] . Thus, FLASH is rapidly degraded during the early stages of apoptosis independent of the induction method.
FLASH mRNA ( Figure 5E ) was found to be relatively stable with a half-life of approximately 6 hours as indicated by exposing the cells to the transcriptional inhibitor, actinomycin D. In contrast, exposure of the cells to cycloheximide, an inhibitor of protein synthesis ( Figure 5F ) suggests that the FLASH protein turns over rapidly (half-life 2-3 hours) raising the possibility that down-regulation of FLASH levels could be due to proteasomal degradation. However, since in the presence of MG132, FLASH degradation was blocked by the specific caspase inhibitors ( Figure 5B) , it is more likely that FLASH is degraded by caspases during apoptosis.
Anti-apoptotic proteins were down regulated when FLASH was depleted
The effect of silencing FLASH gene expression on several proteins implicated in apoptosis was assessed in HT1080 and MCF-10A cells. Both coilin siRNA and scrambled siRNA served as controls and three different FLASH siRNAs were tested. None of the proteins tested were affected by coilin siRNA or scrambled siRNA. Histone H3 levels were clearly reduced in FLASH depleted cells consistent with the result showing that FLASH knockdown causes cell cycle arrest ( Figure 6A ) by down regulating the synthesis of histones [8] . FLASH knockdown significantly reduced the intracellular levels of two anti-apoptotic proteins, MCL1 and the short isoform of c-FLIP, but not c-FLIP long, in HT1080 ( Figure 6A ). MCL-1 levels were also decreased by FLASH knockdown in MCF-10A cells ( Figure 6B ), but the level of BCL-XL was unaffected.
Suppression of apoptosis by FLASH is p53 dependent
RNA interference was used to reduce the level of p53 in HT1080 cells by approximately 80%. As expected, p53 knockdown ( Figure 7A, lane 1) did not induce significant apoptosis judging from the observation that PARP was not degraded. Similarly, depleting the cells of FLASH or both FLASH and p53 (lanes 3 and 4) did not result in apoptosis. However, FLASH knock down cells with wild type 53 rapidly progressed through apoptosis following stimulation with the Fas ligand (lane 5). In contrast, stimulation of cells in which both FLASH and p53 were knocked down did not undergo apoptosis (lane 6), suggesting that a functional p53 is essential.
To confirm the involvement of p53 in promoting apoptosis upon FLASH knockdown, the expression of the anti-apoptotic protein MCL-1 was assessed in mutant HT1080 cells, 6TG-p53, which over express inactive p53. As shown previously [26] , exposure of the cells to adriamycin, which produces double stranded breaks in DNA, results in up-regulation of p53 and as a result the up-regulation of its target, P21 ( Figure 7B ). These results confirm that although 6TG-p53 cells overproduce p53, the protein lacks transcriptional activity.
Stimulation of the Fas receptor in FLASH depleted wild type cells with a functional p53 gene resulted in down-regulation of MCL-1 (Figure 6 and 7B). However, in the 6TG-p53 cells, transfection with FLASH siRNA did not alter the intracellular level of MCL-1. Collectively, these results indicate that the suppression of apoptosis by FLASH is dependent on transcriptionally active, p53.
Discussion
In accord with previous studies [10] , we find that FLASH is a nuclear protein localized within nuclear bodies, primarily but not exclusively within histone gene clusters, where it co localizes with NPAT. A fraction of FLASH was associated with other nuclear bodies although colocalization with PLM bodies appeared to be minimal. We also found that depletion of FLASH lead to a decrease in histone H3 in the cell and arrest in the S phase of the cell cycle.
An unanticipated result of this study was that FLASH was found to be anti-apoptotic, whereas previous work indicated that it promotes apoptosis. Imai et al [1] observed that over expression of FLASH resulted in an approximately 25% increase in apoptosis as judged by the altered morphology of the cells. It may be significant that our studies were conducted with the Type II cells in which activation of the mitochondrial pathway is paramount [3] .
Similarly, Milovic-Holm et al. [7] found that FLASH was proapoptotic although the mechanism proposed was quite different than that suggested by Imai et al. [1] . They found that depletion of FLASH by siRNA interference followed by induction of the Fas receptor with anti-Fas antibody for 7 hours resulted in an approximately 57% decrease in apoptosis. They proposed that activation of the receptor resulted in translocation of FLASH from nuclear bodies to the mitochondria where it activates caspase-8. These authors also conducted their studies with HT1080 cells, the same cells we used in this study. However, there may be differences in strain, P53 status, growth conditions, and methods of induction or antibody titer that could account for the differences in the results. In assessing the effect of FLASH knockdown on apoptosis, these authors [7] induced with the anti-Fas antibody but with far lower concentrations than we employed in our studies (0.025 mg/ml versus 1 mg/ml). Although differences in antibody titer cannot be ruled out, it is perhaps significant that these authors found that the suppression of apoptosis resulting from FLASH depletion was significantly impaired at higher concentrations of the Fas antibody.
The evidence presented here that FLASH, can also suppress apoptosis is compelling. The acceleration of FasL induced apoptosis by FLASH depletion was observed with three different siRNAs that targeted different regions of the FLASH mRNA. Transfection with FLASH siRNA did not induce apoptosis unless the Fas receptor was stimulated but growth was arrested in S phase. However, when FLASH was depleted, activation of the Fas receptor resulted in 1) more rapid activation of caspase 8 and caspase 3, 2) rapid degradation of PARP, 3) nuclear disintegration and DNA fragmentation and 4) the characteristic morphological changes of the cell. Moreover, like most anti-apoptotic proteins, FLASH was rapidly degraded once apoptosis has been irreversibly initiated. The current study is not the only report indicating that FLASH suppresses apoptosis. A siRNA screen identified 37 proteins essential for cell division [27] . FLASH is one of six proteins that when knocked down results in rapid cell death upon entry into mitosis.
There is precedence for apoptotic proteins playing a dual role. For example, DAXX, a nuclear protein that, like FLASH, is involved in both apoptosis and repression of gene expression has been variously reported to be both pro-and anti-apoptotic. Over expression of Daxx promotes Fas induced apoptosis by direct interaction with the Fas receptor [28] or via a nuclear pathway [29] suggesting that it is pro-apoptotic. The opposite conclusion was drawn from studies of Daxx-knockout embryos and embryonic stem cell lines [30] and by siRNA suppression of Daxx expression [31, 32] . These latter studies showed that depletion of Daxx resulted in an increased sensitivity to Fas mediated or stress induced apoptosis, suggesting an anti-apoptotic function. Whether Daxx promotes or suppresses apoptosis may be dependent on its modification by other signaling pathways. It was recently shown [33] that phosphorylation of Daxx by CK2 kinase promotes the binding of SUMO-1 and stress-induced apoptosis by downregulation of anti-apoptotic regulatory proteins.
The involvement of FLASH in the activation of caspase-8 at the DISC [1] and at the mitochondria [7] is pro-apoptotic, but there are other functions ascribed to FLASH that would be expected to protect against entry into apoptosis.
Stimulation of TNF-a receptor elicits two opposing effects, apoptosis and activation of the anti-apoptotic transcription factor, NF-kappa B [34] . Suppression of FLASH expression has been shown to abolish TNF-a induced activation of NF-kappa B via a TRAF2 dependent pathway in HEK293 cells [21] , an effect that would be expected to stimulate apoptosis. While the relationship between FLASH and Fas signaling has not been investigated, it has been shown that the stimulation of the Fas receptor also activates NF-kappa B in human bladder carcinoma T24 and Jurkat cells [35] and in SK-Hep1 hepatocellular carcinoma cells [36] , so it is likely that FLASH has a comparable role in the Fas receptor signaling that would lead to suppression of apoptosis ( Figure 1) .
Another FLASH function consistent with an anti-apoptotic role is that it serves as an important coactivator of cMyb [16, 17] , a transcription factor generally considered to promote growth and survival (Figure 1 ). c-Myb is a major target of glycogen synthase kinase 3b (GSK3b). Inhibition of GSK3b results in ubiquitin mediated degradation of cMyb and the induction of apoptosis by inhibiting the expression of BCL2 and survivin [37] . Survivin, a caspase inhibitor [38] , may not be relevant since it is expressed primarily during G2 and FLASH knockdown arrest cell cycle progression in S phase [39] . BCL-2 is a potent inhibitor of apoptosis that blocks the function of the death inducing protein Bak at the mitochondrial membrane. However, we did not find a significant decrease in the BCL-2 levels when FLASH was depleted suggesting that it also does not play a role in the suppression of apoptosis by FLASH.
In agreement with Barcaroli et al [8] , we found that FLASH colocalizes with NPAT in histone gene clusters. Moreover, the intracellular level of histone H3 is dramatically reduced upon FLASH depletion and the cells accumulate in S phase. Normally, cell cycle arrest in S-phase is not sufficient to induce apoptosis. However, the failure to assemble functional nucleosomes to protect the newly synthesized DNA may accelerate the onset of apoptosis when the cells are stimulated by FasL.
Suppression of apoptosis by FLASH was found to be dependent on the transcription factor, p53. In cells depleted of endogenous p53 by siRNA interference, knock down of FLASH had an appreciably smaller stimulatory effect on apoptosis when the Fas receptor was activated ( Figure 5B ). Similarly, in HT1080 cells harboring a mutant p53, FLASH knockdown did not significantly enhance the apoptotic response. P53 is known to regulate the expression of several pro-and anti-apoptotic proteins [40] . Previous studies suggested that P53 down-regulates the expression of the anti-apoptotic protein, MCL-1 up to 30-fold [40] . In this study, depletion of FLASH resulted in significant reduction in the level of MCL-1 in the cell. The lower concentration of MCL-1 would be expected to relieve its inhibitory effect on the formation of the mitochondrial channel and promote apoptosis.
The other anti-apoptotic protein that we found down regulated by FLASH depletion is the short isoform of c-FLIP (cellular FLICE inhibitory protein) which acts directly at the Fas deathinducing DISC complex inhibiting caspase-8 activation and Fas receptor mediated apoptosis [41] . In hepatocellular carcinoma cells, c-FLIP is the major regulator of cell death and survival. In addition to inhibiting caspase activation, c-FLIP is a potent inhibitor of apoptosis by inhibiting the activation of NF-kappa B [42] . The function of the long isoform c-FLIP has been controversial, but recent studies indicate that it can be either pro-or anti-apoptotic depending on the circumstances [41, 43] .
The precise role that FLASH may play regulation of intracellular level of MCL-1 and c-FLIP short remains to be determined. Previous studies showed that FLASH promotes both activation and repression of gene expression depending on the specific gene under consideration [8, 15, 16, 17, 18, 19, 20, 21] and thus it may modulate the level of these anti-apoptotic proteins. Alternatively, both MCL-1 and c-FLIP short are short lived proteins [44, 45] , so the reduced intracellular levels of these proteins upon FLASH depletion may result from the destabilization of these proteins as a consequence of cell cycle arrest in S phase.
While there are several functional connections between FLASH and various key factors in the apoptotic pathways, the mechanism by which FLASH suppresses apoptosis remains to be deciphered. Of particular interest, is the identification of the switch that determines whether FLASH functions to promote or suppress apoptosis. Very little is known regarding the regulation of FLASH function, however, FLASH has been shown to interact with the SUMO-conjugation enzyme, Ubc9 [46] . Sumoylation attenuates the transcriptional activity of FLASH as measured by the Gal4 tethering assay. Given the size and complexity of FLASH, other regulatory mechanisms are likely to be discovered.
